Month: June 2022

BGNE_Logo_0821-3

BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma

PD-1 inhibitor tislelizumab plus chemotherapy demonstrated a statistically significant and clinically meaningful survival benefit, extending survival by more than six...

FAS

AIA Singapore introduces more than 500 financial sales advisory positions under new employment scheme providing greater financial stability to attract fresh graduates, mid-career switchers and stay-at-home-parents keen to return to the workforce